<SEC-DOCUMENT>0001854270-22-000018.txt : 20220815
<SEC-HEADER>0001854270-22-000018.hdr.sgml : 20220815
<ACCEPTANCE-DATETIME>20220815160643
ACCESSION NUMBER:		0001854270-22-000018
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20220815
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220815
DATE AS OF CHANGE:		20220815

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Senti Biosciences, Inc.
		CENTRAL INDEX KEY:			0001854270
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				862437900
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40440
		FILM NUMBER:		221165657

	BUSINESS ADDRESS:	
		STREET 1:		2 CORPORATE DRIVE, FIRST FLOOR
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 382-3281

	MAIL ADDRESS:	
		STREET 1:		2 CORPORATE DRIVE, FIRST FLOOR
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Senti Biosciences, Inc.\
		DATE OF NAME CHANGE:	20220615

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Dynamics Special Purpose Corp.
		DATE OF NAME CHANGE:	20210331
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>snti-20220815.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:17db125a-912d-434a-872f-aacd20518dd5,g:83f0ca8f-c503-4cb7-9a97-098145bce5bc,d:e13a669b8584420e901128e9a61822a4--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>snti-20220815</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF80L2ZyYWc6MzBhNTA2ZmYwNTZjNGJjNWFmMDgxYTczYWYxNzQ5Y2QvdGFibGU6YjkzNGFlY2M5MDAxNDFkNTg4OWQzYTNiM2IyOTYzMmEvdGFibGVyYW5nZTpiOTM0YWVjYzkwMDE0MWQ1ODg5ZDNhM2IzYjI5NjMyYV8xLTEtMS0xLTk3MDk5_aaacecfb-f936-4d6a-b3b1-69805fff213a">0001854270</ix:nonNumeric><ix:nonNumeric contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF80L2ZyYWc6MzBhNTA2ZmYwNTZjNGJjNWFmMDgxYTczYWYxNzQ5Y2QvdGFibGU6YjkzNGFlY2M5MDAxNDFkNTg4OWQzYTNiM2IyOTYzMmEvdGFibGVyYW5nZTpiOTM0YWVjYzkwMDE0MWQ1ODg5ZDNhM2IzYjI5NjMyYV8yLTEtMS0xLTk3MDk5_c18af3b6-ca7d-4f59-b95f-3f05c72f62a7">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="snti-20220815.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="iedad022569ab46589d8088865d4a1647_D20220815-20220815"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001854270</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-15</xbrli:startDate><xbrli:endDate>2022-08-15</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ie13a669b8584420e901128e9a61822a4_1"></div><div style="min-height:31.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:115%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:115%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Washington, D.C. 20549</span></div><div style="margin-bottom:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:115%">___________________________________</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:115%">FORM <ix:nonNumeric contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGV4dHJlZ2lvbjo5MTRlMWVlMzcxNGE0MjJkODRlYzVmMThmNThiMTc3Ml8xNTAx_1ba8aeb5-948f-4ed5-8739-de403d6ad49e">8-K</ix:nonNumeric></span></div><div style="margin-bottom:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:115%">___________________________________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Pursuant to Section 13 or 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">of the Securities Exchange Act of 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGV4dHJlZ2lvbjo5MTRlMWVlMzcxNGE0MjJkODRlYzVmMThmNThiMTc3Ml8yOTU_c12218ed-c90b-4541-af43-9d44cd6b038e">August 15, 2022</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="margin-bottom:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:115%">___________________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGV4dHJlZ2lvbjo5MTRlMWVlMzcxNGE0MjJkODRlYzVmMThmNThiMTc3Ml8xNTAz_9861ed99-27f4-4428-8878-78687109bf8e">SENTI BIOSCIENCES, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:115%">___________________________________</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"></td><td style="width:31.726%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.726%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.730%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGFibGU6ZjA3MmQxNzc2ZmFlNDAzMzk2YmY1MWM3YzhjN2RiYzIvdGFibGVyYW5nZTpmMDcyZDE3NzZmYWU0MDMzOTZiZjUxYzdjOGM3ZGJjMl8wLTAtMS0xLTk3MDk5_76e84846-03ed-4665-9e1f-e9d88074a944">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGFibGU6ZjA3MmQxNzc2ZmFlNDAzMzk2YmY1MWM3YzhjN2RiYzIvdGFibGVyYW5nZTpmMDcyZDE3NzZmYWU0MDMzOTZiZjUxYzdjOGM3ZGJjMl8wLTItMS0xLTk3MDk5_51d9fe62-b599-4204-8dda-1ab43915da0b">001-40440</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGFibGU6ZjA3MmQxNzc2ZmFlNDAzMzk2YmY1MWM3YzhjN2RiYzIvdGFibGVyYW5nZTpmMDcyZDE3NzZmYWU0MDMzOTZiZjUxYzdjOGM3ZGJjMl8wLTQtMS0xLTk3MDk5_aa823154-7d27-4e9b-9816-2b9b384a4b14">86-2437900</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(State or other jurisdiction</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">of incorporation)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(Commission</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(IRS Employer</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Identification No.)</span></div></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGV4dHJlZ2lvbjo5MTRlMWVlMzcxNGE0MjJkODRlYzVmMThmNThiMTc3Ml8xNTA0_c82ca0a9-db6c-496f-852c-d43593ba2ef5">2 Corporate Drive, First Floor</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGV4dHJlZ2lvbjo5MTRlMWVlMzcxNGE0MjJkODRlYzVmMThmNThiMTc3Ml8xNTA1_e5071077-d917-4bf0-bd6f-83d9d0bc45f1">South San Francisco</ix:nonNumeric>, <ix:nonNumeric contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGV4dHJlZ2lvbjo5MTRlMWVlMzcxNGE0MjJkODRlYzVmMThmNThiMTc3Ml8xNTA2_23284f29-5057-4f0a-980f-bb1505aa752c">California</ix:nonNumeric> <ix:nonNumeric contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGV4dHJlZ2lvbjo5MTRlMWVlMzcxNGE0MjJkODRlYzVmMThmNThiMTc3Ml81MTg_ccee2189-91a8-47c3-b338-e9115d3db8db">94080</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(Address of principal executive offices including zip code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGV4dHJlZ2lvbjo5MTRlMWVlMzcxNGE0MjJkODRlYzVmMThmNThiMTc3Ml82MzQ_cd70187d-0e06-4ca2-a121-7953d954edef">650</ix:nonNumeric>) <ix:nonNumeric contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGV4dHJlZ2lvbjo5MTRlMWVlMzcxNGE0MjJkODRlYzVmMThmNThiMTc3Ml82Mzg_7ccd335a-a0d0-4787-bc08-6fb16d32a23e">382-3281</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(Former name or former address, if changed since last report)</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="margin-bottom:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:115%">___________________________________</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%"> </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:2.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.955%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGFibGU6M2M0NjY4NmYzMGYzNDBjYTljMzViNmU4ZjM2YzUyNzMvdGFibGVyYW5nZTozYzQ2Njg2ZjMwZjM0MGNhOWMzNWI2ZThmMzZjNTI3M18wLTAtMS0xLTk3MDk5_a85b7ef8-d496-4317-92d7-696c8f7666d5">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGFibGU6M2M0NjY4NmYzMGYzNDBjYTljMzViNmU4ZjM2YzUyNzMvdGFibGVyYW5nZTozYzQ2Njg2ZjMwZjM0MGNhOWMzNWI2ZThmMzZjNTI3M18yLTAtMS0xLTk3MDk5_65e4a9d4-d379-46ce-90e3-7e30f389ca25">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGFibGU6M2M0NjY4NmYzMGYzNDBjYTljMzViNmU4ZjM2YzUyNzMvdGFibGVyYW5nZTozYzQ2Njg2ZjMwZjM0MGNhOWMzNWI2ZThmMzZjNTI3M180LTAtMS0xLTk3MDk5_4ca5a39e-58bc-474a-91dc-44cd6892dd84">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGFibGU6M2M0NjY4NmYzMGYzNDBjYTljMzViNmU4ZjM2YzUyNzMvdGFibGVyYW5nZTozYzQ2Njg2ZjMwZjM0MGNhOWMzNWI2ZThmMzZjNTI3M182LTAtMS0xLTk3MDk5_c997b641-e9af-4136-8f84-becb30a8a263">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:43.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.170%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Trading</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Symbol</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Name of each exchange</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">on which registered</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGFibGU6YjgzZjdiNTE4NThjNGE4MTk5MTEyYTNjNTVlYzIyOTAvdGFibGVyYW5nZTpiODNmN2I1MTg1OGM0YTgxOTkxMTJhM2M1NWVjMjI5MF8xLTAtMS0xLTk3MDk5_c33fb9e2-019f-441e-b163-8b53941f9832">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGFibGU6YjgzZjdiNTE4NThjNGE4MTk5MTEyYTNjNTVlYzIyOTAvdGFibGVyYW5nZTpiODNmN2I1MTg1OGM0YTgxOTkxMTJhM2M1NWVjMjI5MF8xLTItMS0xLTk3MDk5_88fa3dab-d47c-46ed-b6ec-bf0253d54251">SNTI</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGFibGU6YjgzZjdiNTE4NThjNGE4MTk5MTEyYTNjNTVlYzIyOTAvdGFibGVyYW5nZTpiODNmN2I1MTg1OGM0YTgxOTkxMTJhM2M1NWVjMjI5MF8xLTQtMS0xLTk3MDk5_50f2e64a-c436-4f85-a794-5b57a4ad8631">The Nasdaq Global Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Emerging growth company <ix:nonNumeric contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGV4dHJlZ2lvbjo5MTRlMWVlMzcxNGE0MjJkODRlYzVmMThmNThiMTc3Ml8xNDk5_392eb7ba-ce20-4006-b582-c3f989e3b56e">&#9746;</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGV4dHJlZ2lvbjo5MTRlMWVlMzcxNGE0MjJkODRlYzVmMThmNThiMTc3Ml8xNTAw_fd3e9e16-c269-420c-ae5b-e5ace49b323d">&#9746;</ix:nonNumeric></span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div></div></div><div id="ie13a669b8584420e901128e9a61822a4_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 2.02 Results of Operations and Financial Condition.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 15, 2022, Senti Biosciences, Inc. (the &#8220;Company&#8221;) issued a press release announcing its financial results for the quarter ended June 30, 2022. A copy of this earnings release is furnished hereto as Exhibit 99.1.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In accordance with General Instruction B.2. of Form 8-K, the information in Items 2.02 and 9.01 of this report, including the exhibits, is intended to be furnished and shall not be deemed to be &#8220;filed&#8221; for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended or the Exchange Act.</span></div><div><span><br/></span></div><div id="ie13a669b8584420e901128e9a61822a4_76"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 9.01 Financial Statements and Exhibits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(d) Exhibits</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.939%"><tr><td style="width:1.0%"></td><td style="width:13.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.417%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a202208158kex991.htm">Press Release, dated August 1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a202208158kex991.htm">5</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a202208158kex991.htm">, 2022</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ie13a669b8584420e901128e9a61822a4_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">SIGNATURE</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.811%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">SENTI BIOSCIENCES, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">August 15, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ Timothy Lu</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Name:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Timothy Lu, M.D., Ph.D.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chief Executive Officer &amp; President</span></td></tr></table></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a202208158kex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ica2f612294e34e818c85e52a90f77572_33"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><img alt="senti_logoxpra.jpg" src="senti_logoxpra.jpg" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:166px"></div></div><div style="text-align:center"><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Senti Bio Reports Second Quarter Financial Results and Business Updates</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">- Lead development candidate selected from SENTI-202 program&#59; on track for IND filing in 2023 -</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">- Expect to present CAR-NK cell therapy program data at multiple scientific conferences in 2022 -</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">- Cash position of $139.8 million as of June 30, 2022 expected to fund current operating plan into 2024 -</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:112%">South San Francisco, Calif., August 15, 2022</font><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> &#8212; Senti Biosciences, Inc. (Nasdaq&#58; SNTI) (&#8220;Senti Bio&#8221;), a </font><font style="background-color:#ffffff;color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">biotechnology company innovating next-generation cell and gene therapies using its proprietary gene circuit platform, today reported financial results for the second quarter ended June 30, 2022, and highlighted recent corporate accomplishments, including the selection of a lead development candidate from its SENTI-202 program with an anticipated Investigational New Drug (IND) application in 2023.</font></div><div><font><br></font></div><div><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;We continued to invest in our gene circuit technology platform while advancing oncology programs toward the clinic, including two IND filings on track for 2023, the first of which we anticipate will be from our SENTI-202 program for the treatment of acute myeloid leukemia (AML). I am extremely proud of our team for their work that enabled the achievement of one of our most significant milestones to date&#8212;the selection of our first development candidate that uses CAR-NK cells engineered with Logic Gating and Multi-Arming gene circuits,&#8221; said Timothy Lu, MD, PhD, Chief Executive Officer and Co-Founder of Senti Bio. &#8220;We believe that our approach to engineering gene circuits has the potential to improve the next-generation of cell and gene therapies by enhancing the specificity and efficacy of treatments for people living with cancer.&#8221;</font></div><div><font><br></font></div><div><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dr. Lu added, &#8220;</font><font style="background-color:#ffffff;color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">With our recent capital raise, we are well positioned to advance our pipeline toward clinical </font><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">development. We also added new talent to our organization, including </font><font style="background-color:#ffffff;color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dr. Kanya Rajangam, our Chief Medical and Development Officer. I remain</font><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> extremely grateful to our employees and investors who share Senti Bio&#8217;s vision of creating a new generation of smarter medicines that outmaneuver complex diseases.&#8221;</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Recent Business Highlights </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">CAR-NK Cell Oncology Pipeline and Gene Circuit Platform Highlights&#58;</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Senti Bio is developing next-generation cell and gene therapies engineered with gene circuits, which reprogram cells with biological logic to sense inputs, compute decisions and respond to disease environments. These gene circuits are designed to enhance the selective cytotoxicity of chimeric antigen receptor natural killer (CAR-NK) cells against tumor cells, and to overcome the suppressive tumor microenvironment to potentially solve unmet needs across a wide variety of cancers. Senti Bio&#8217;s oncology pipeline uses healthy adult donor-derived, CAR-NK cells that are engineered with gene circuits and can be cryopreserved and dosed off-the-shelf.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:112%">SENTI-202&#58;</font><font style="background-color:#ffffff;color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> A Logic Gated (OR+NOT) off-the-shelf CAR-NK cell therapy development candidate designed to selectively target and eliminate AML cells while sparing the healthy bone marrow.</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="background-color:#ffffff;color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.02pt">Selected lead development candidate from SENTI-202 program based on extensive optimization using Senti Bio&#8217;s proprietary screening platform for off-the-shelf CAR-NK cells.</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="background-color:#ffffff;color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.02pt">Presented preclinical data demonstrating the use of Logic Gating gene circuits to </font><font style="color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">target and eliminate AML cells while sparing the healthy bone marrow at the American Society of Gene and Cell Therapy (ASGCT) meeting</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font><font style="color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">in May 2022.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.02pt">Initiated manufacturing and IND-enabling activities, including pharmacology&#47;toxicology studies and clinical trial design for patients with relapsed&#47;refractory AML, to support a 2023 IND filing.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:112%">SENTI-301&#58;</font><font style="background-color:#ffffff;color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> A Multi-Armed off-the-shelf CAR-NK cell therapy development program designed for the treatment of hepatocellular carcinoma (HCC).</font></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="background-color:#ffffff;color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.02pt">Presented preclinical data demonstrating the use of gene circuits to </font><font style="background-color:#ffffff;color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">improve the cytotoxicity and persistence of CAR-NK cells in treating HCC at the ASGCT meeting.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><img alt="senti_logoxpra.jpg" src="senti_logoxpra.jpg" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:166px"></div></div><div><font style="background-color:#ffffff;color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:112%">SENTI-401&#58;</font><font style="background-color:#ffffff;color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> A Logic Gated (NOT) off-the-shelf selective CAR-NK cell therapy development program designed to target and eliminate colorectal cancer (CRC) cells while sparing healthy cells in the body.</font></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="background-color:#ffffff;color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.02pt">Presented preclinical data demonstrating the use of gene circuits to target CEA-expressing cancer cells, including CRC cells at American Association for Cancer Research (AACR) meeting in April 2022.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Manufacturing Facility Update</font><font style="background-color:#ffffff;color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#58; </font></div><div><font style="background-color:#ffffff;color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Construction at Senti Bio&#8217;s &#126;92,000 square foot facility in Alameda, CA is on track for facility startup by year-end 2022 to support clinical manufacturing of Senti Bio&#8217;s CAR-NK cells in 2023.</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="background-color:#ffffff;color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.02pt">The facility is designed from the ground up to support Senti Bio&#8217;s gene circuit engineered off-the-shelf cell therapies, including seven flexible cGMP processing suites, quality control and testing laboratories, manufacturing science &#38; technology labs, and storage and supply chain capabilities for cryopreserved products.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="background-color:#ffffff;color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.02pt">Additional capacity expansion is available to support future product candidates as well as commercial scale manufacturing.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Other Corporate Highlights&#58;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="background-color:#ffffff;color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.02pt">Became a public company on Nasdaq, resulting in gross proceeds</font><font style="color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of $140.7M to Sent</font><font style="background-color:#ffffff;color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">i Bio.</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="background-color:#ffffff;color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.02pt">Strengthened the management team with the hiring of experienced cell therapy and oncology drug development executive Dr. Kanya Rajangam as Chief Medical and Development Officer, to lead off-the-shelf CAR-NK cell oncology programs into and through clinical development.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="background-color:#ffffff;color:#3c4043;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.02pt">Expanded the Board of Directors with the addition of David Epstein, executive partner at Flagship Pioneering and former CEO of Novartis Pharmaceuticals&#59; Dr. Omid Farokhzad, Founder and CEO of Seer Inc.&#59; and Senti Bio Co-founder Dr. James Collins, Professor of Biological Engineering at Massachusetts Institute of Technology.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Second Quarter 2022 Financial Results</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="background-color:#ffffff;color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.02pt">Cash and Cash Equivalents&#58; As of June 30, 2022, Senti Bio held cash and cash equivalents of $139.8 million, which the Company believes is sufficient </font><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">to fund operations into 2024.</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="background-color:#ffffff;color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.02pt">R&#38;D Expenses&#58; Research &#38; development expenses were $9.2 million for the quarter ended June 30, 2022, compared to $5.2 million for the same period in 2021. The increase includes an additional $1.3 million in non-cash stock-based compensation expense.</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="background-color:#ffffff;color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.02pt">G&#38;A Expenses&#58; General and administrative expenses were $13.9 million for the second quarter of 2022, compared to $4.6 million for the same period in 2021. The increase includes an additional $7.4 million in non-cash stock-based compensation expense.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="background-color:#ffffff;color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.02pt">Net Loss&#58; Net loss was $11.6 million, </font><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">or $0.86 </font><font style="background-color:#ffffff;color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">per basic and diluted share, for the quarter ended June 30, 2022.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:112%">About SENTI-202</font></div><div><font style="background-color:#ffffff;color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SENTI-202 is intended to treat AML, employs an OR Logic Gate and a NOT Logic Gate gene circuit to selectively kill cancer cells with broader spectrum activity while sparing healthy cells, and is also Multi-Armed with calibrated release interleukin-15 (crIL-15) to promote NK cell persistence and tumor killing.</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="background-color:#ffffff;color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.02pt">OR GATE&#58; Bivalent FLT3 OR CD33 Logic Gated activating CAR (aCAR) is engineered to increase AML leukemic stem cell (LSC) and blast clearance by targeting cancer cells expressing FLT3, CD33, or both, thus reducing single antigen tumor escape, and potentially providing deeper and longer remissions.</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="background-color:#ffffff;color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.02pt">NOT GATE&#58; Endomucin (EMCN) NOT Logic Gated inhibitory CAR (iCAR) is engineered to protect healthy hematopoietic stem cells that are EMCN positive (EMCN+) from off-tumor toxicity, potentially increasing therapeutic specificity and improving post-treatment regeneration of a healthy hematopoietic system.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="background-color:#ffffff;color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.02pt">Calibrated release interleukin-15&#58; The crIL-15 construct is designed to simultaneously produce both membrane-associated and fully secreted IL-15, enabling both autocrine signaling (to increase CAR-NK cell proliferation and persistence) and paracrine signaling (to stimulate the patient's surrounding immune cells).</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><img alt="senti_logoxpra.jpg" src="senti_logoxpra.jpg" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:166px"></div></div><div><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:112%">About Senti Bio</font></div><div><font style="color:#262626;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our mission is to create a new generation of smarter medicines that outmaneuver complex diseases using novel and unprecedented approaches. To accomplish this, we are building a synthetic biology platform that may enable us to program next-generation cell and gene therapies with what we refer to as Gene Circuits. These Gene Circuits, which are created from novel and proprietary combinations of DNA sequences, are designed to reprogram cells with biological logic to sense inputs, compute decisions and respond to their cellular environments. We aim to design Gene Circuits to improve the intelligence of cell and gene therapies in order to enhance their therapeutic effectiveness, precision, and durability against a broad range of diseases that conventional medicines do not readily address.</font></div><div><font><br></font></div><div><font style="color:#262626;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our synthetic biology platform utilizes off-the-shelf chimeric antigen receptor natural killer (CAR-NK) cells, outfitted with Gene Circuit technologies, to target particularly challenging liquid and solid tumor oncology indications. Our lead development candidate is SENTI-202 for the treatment of acute myeloid leukemia (AML). Additional CAR-NK programs include SENTI-301 for the treatment of hepatocellular carcinoma (HCC) and SENTI-401 for the treatment of colorectal cancer (CRC). We have also demonstrated the breadth of our Gene Circuits in other modalities and diseases outside of oncology and have executed partnerships with Spark Therapeutics and BlueRock Therapeutics to advance these capabilities.</font></div><div><font><br></font></div><div><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Forward-Looking Statements</font></div><div><font style="color:#0e101a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This document contains certain statements that are not historical facts and are considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally are identified by the words &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;predict,&#8221; &#8220;continue,&#8221; &#8220;ongoing,&#8221; &#8220;project,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;intend,&#8221; &#8220;strategy,&#8221; &#8220;future,&#8221; &#8220;opportunity,&#8221; &#8220;plan,&#8221; &#8220;may,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;will be,&#8221; &#8220;will continue,&#8221; &#8220;will likely result,&#8221; &#8220;forecast,&#8221; &#8220;seek,&#8221; &#8220;target&#8221; and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations of Senti Bio&#8217;s management and assumptions, whether or not identified in this document, and, as a result, are subject to risks and uncertainties. Forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of financial and cash runway, Senti Bio&#8217;s ability to continue to advance its pipeline of preclinical programs and product candidates, Senti Bio&#8217;s research and development activities, release of additional preclinical data, commencement of IND-enabling studies and submission of IND filings, and GMP manufacturing start up activities, as well as statements about the potential attributes and benefits of Senti Bio&#8217;s product candidates and platform technology. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Senti Bio. Many factors could cause actual future events to differ materially from the forward-looking statements in this document, including but not limited to&#58; (i) changes in domestic and foreign business, market, financial, political and legal conditions, (ii) changes in the competitive and highly regulated industries in which Senti Bio operates, variations in operating performance across competitors, changes in laws and regulations affecting Senti Bio&#8217;s business (iii) the ability to implement business plans, forecasts and other expectations, (iv) the risk of downturns and a changing regulatory landscape in Senti Bio&#8217;s highly competitive industry, (v) risks relating to the uncertainty of any projected financial information with respect to Senti Bio, (vi) risks related to uncertainty in the timing or results of Senti Bio&#8217;s preclinical studies, IND filings, and GMP manufacturing startup activities, (vii) Senti Bio&#8217;s dependence on third parties in connection with preclinical and IND-enabling studies, IND filing, and GMP manufacturing buildout and startup activities, (viii) risks related to delays and other impacts from the COVID-19 pandemic, and (ix) the success of any future research and development efforts by Senti Bio. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the &#8220;Risk Factors&#8221; section of Senti Bio&#8217;s registration statement on Form S-1 (File No. 333-265873), and other documents filed by Senti Bio from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements in this document. There may be additional risks that Senti Bio does not presently know, or that Senti Bio currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements in this document. Forward-looking statements speak only as of the date they are made. Senti Bio anticipates that subsequent events and developments may cause Senti Bio&#8217;s assessments to change. Except as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><img alt="senti_logoxpra.jpg" src="senti_logoxpra.jpg" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:166px"></div></div><div><font style="color:#0e101a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">required by law, Senti Bio assumes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise.</font></div><div><font><br></font></div><div><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Availability of Other Information About Senti Biosciences, Inc.</font></div><div><font style="color:#262626;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For more information, please visit the Senti Bio website at https&#58;&#47;&#47;www.sentibio.com or follow Senti Bio on Twitter (</font><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">&#64;SentiBio</font><font style="color:#262626;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">) and LinkedIn (</font><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Senti Biosciences). </font><font style="color:#262626;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Investors and others should note that we communicate with our investors and the public using our company website (www.sentibio.com), including, but not limited to, company disclosures, investor presentations and FAQs, Securities and Exchange Commission filings, press releases, public conference call transcripts and webcast transcripts, as well as on Twitter and LinkedIn. The information that we post on our website or on Twitter or LinkedIn could be deemed to be material information. As a result, we encourage investors, the media and others interested to review the information that we post there on a regular basis. The contents of our website or social media shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.</font></div><div><font><br></font></div><div><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Contact Senti Bio&#58;</font></div><div><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Deb Knobelman, PhD, CFO </font></div><div><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">investors&#64;sentibio.com</font></div><div><font><br></font></div><div><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Media&#58;</font></div><div><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Kelli Perkins</font></div><div><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">kelli&#64;redhousecomms.com</font></div><div><font><br></font></div><div><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Find more information at </font><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">sentibio.com</font></div><div><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Follow us on Linkedin&#58; </font><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Senti Biosciences</font></div><div><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Follow us on Twitter&#58; </font><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">&#64;SentiBio</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ica2f612294e34e818c85e52a90f77572_80"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><img alt="senti_logoxpra.jpg" src="senti_logoxpra.jpg" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:166px"></div></div><div style="text-align:center"><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Senti Biosciences, Inc.</font></div><div style="text-align:center"><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Unaudited Selected Consolidated Balance Sheet Data</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(in thousands)</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.323%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.048%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,800&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,034&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,257&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,257&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</font></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,505&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,368&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,474&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,708&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</font></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,362&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,702&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,096&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,326&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock</font></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,833&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity (deficit)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,266&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111,457)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Senti Biosciences, Inc.</font></div><div style="text-align:center"><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Unaudited Consolidated Statements of Operations</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#404040;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:112%">(in thousands, except share and per share data)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.053%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</font></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">865&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</font></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,247&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,235&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,849&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,138&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,882&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,554&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,141&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,865&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</font></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,129&#160;</font></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,789&#160;</font></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,990&#160;</font></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,003&#160;</font></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,771)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,996)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,528)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,138)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense), net</font></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,219&#160;</font></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,011)</font></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,168&#160;</font></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,871)</font></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,552)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,007)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,360)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,009)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.86)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.13)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.80)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.45)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding, basic and diluted</font></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,446,622&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,909,105&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,336,451&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,883,582&#160;</font></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>snti-20220815.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:17db125a-912d-434a-872f-aacd20518dd5,g:83f0ca8f-c503-4cb7-9a97-098145bce5bc-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:snti="http://www.sentibio.com/20220815" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.sentibio.com/20220815">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="snti-20220815_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="snti-20220815_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.sentibio.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>snti-20220815_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:17db125a-912d-434a-872f-aacd20518dd5,g:83f0ca8f-c503-4cb7-9a97-098145bce5bc-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityCentralIndexKey_8d1084b5-d600-4b14-95c4-072cd94f553d_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_12425d70-3844-48b5-9342-7086f75f7e46_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_e15fa73d-9f75-45df-9390-a60f6d6c09c3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_5dee5441-f602-4d20-a9fd-b64c91c3364a_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_549d0ca5-c789-4d3a-a47b-92df4da33e21_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_63b22641-b481-42dd-b14b-d549cc6b1647_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_47864791-1959-4269-98df-dfd3cf26b07d_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_0f45128d-8885-4442-8169-2bdaa6a43c21_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_c76664fa-c424-44d5-b6c6-aafed249f94d_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_62ee531b-1e4d-418a-ba8c-6ff4302975e6_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_a8ddc52a-d4c4-46e3-962c-75ce16359a56_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_1171e3a6-762c-4b65-9eab-d309dee9d3bc_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_22765d00-e265-48b1-9665-8f8472ca673b_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_b5261897-bcb5-4bf0-a1d9-cdd2e41637a1_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_f0ebc2de-080e-4e2a-a754-fead64171374_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_1d5f6f4a-8618-4859-aaab-70548548349c_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_2be0da40-d013-4927-bbc2-254b61514347_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_146b0604-5755-4fa8-bee9-69bfa1a13418_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_2528349e-6795-445c-a261-6213d981c577_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_b36b8104-21ad-4723-9915-4b5bb463544a_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_8dc1965d-ae09-4170-8bee-3c10c785f8fc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_0de8d37c-7d63-4c09-83d7-b3fb97ed78b5_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_97760ede-ae49-43b5-a0c2-3b594010062c_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>snti-20220815_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:17db125a-912d-434a-872f-aacd20518dd5,g:83f0ca8f-c503-4cb7-9a97-098145bce5bc-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.sentibio.com/role/Cover" xlink:type="simple" xlink:href="snti-20220815.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.sentibio.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_1a9a4ebb-cf0e-46f8-860b-5888ce87e7e5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_e615b532-3be2-4dda-a89e-89c6abb103cf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a9a4ebb-cf0e-46f8-860b-5888ce87e7e5" xlink:to="loc_dei_DocumentType_e615b532-3be2-4dda-a89e-89c6abb103cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_6cce0a9c-ac89-4f31-95c0-a885a936f408" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a9a4ebb-cf0e-46f8-860b-5888ce87e7e5" xlink:to="loc_dei_DocumentPeriodEndDate_6cce0a9c-ac89-4f31-95c0-a885a936f408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_1d4bbacb-1e82-499d-881f-68f3dbcc3b8e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a9a4ebb-cf0e-46f8-860b-5888ce87e7e5" xlink:to="loc_dei_EntityRegistrantName_1d4bbacb-1e82-499d-881f-68f3dbcc3b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_34473886-0854-4317-9786-640947d31a21" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a9a4ebb-cf0e-46f8-860b-5888ce87e7e5" xlink:to="loc_dei_EntityIncorporationStateCountryCode_34473886-0854-4317-9786-640947d31a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_8190148c-7b24-4edd-8c33-4fa0436f6e1c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a9a4ebb-cf0e-46f8-860b-5888ce87e7e5" xlink:to="loc_dei_EntityFileNumber_8190148c-7b24-4edd-8c33-4fa0436f6e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_5905b43d-1c2b-4a97-921e-ab2173d247c5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a9a4ebb-cf0e-46f8-860b-5888ce87e7e5" xlink:to="loc_dei_EntityTaxIdentificationNumber_5905b43d-1c2b-4a97-921e-ab2173d247c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_60a7dad5-4cf8-40d7-a188-77602b6bbbd8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a9a4ebb-cf0e-46f8-860b-5888ce87e7e5" xlink:to="loc_dei_EntityAddressAddressLine1_60a7dad5-4cf8-40d7-a188-77602b6bbbd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_a46e825a-355e-4cd4-98df-a0799927a9ff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a9a4ebb-cf0e-46f8-860b-5888ce87e7e5" xlink:to="loc_dei_EntityAddressCityOrTown_a46e825a-355e-4cd4-98df-a0799927a9ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_26554d9b-10f5-4461-8149-e4f619d86a37" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a9a4ebb-cf0e-46f8-860b-5888ce87e7e5" xlink:to="loc_dei_EntityAddressStateOrProvince_26554d9b-10f5-4461-8149-e4f619d86a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c039fe1e-1daa-4ab1-af4c-28f92e79a353" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a9a4ebb-cf0e-46f8-860b-5888ce87e7e5" xlink:to="loc_dei_EntityAddressPostalZipCode_c039fe1e-1daa-4ab1-af4c-28f92e79a353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_dcacd81b-58ca-479b-ba95-35283de37129" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a9a4ebb-cf0e-46f8-860b-5888ce87e7e5" xlink:to="loc_dei_CityAreaCode_dcacd81b-58ca-479b-ba95-35283de37129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_6e79ed5a-89b0-4a0d-ac1b-53ad5bc4eb8a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a9a4ebb-cf0e-46f8-860b-5888ce87e7e5" xlink:to="loc_dei_LocalPhoneNumber_6e79ed5a-89b0-4a0d-ac1b-53ad5bc4eb8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_6cd67c88-e1f3-4e85-adc6-765d60ecf22e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a9a4ebb-cf0e-46f8-860b-5888ce87e7e5" xlink:to="loc_dei_WrittenCommunications_6cd67c88-e1f3-4e85-adc6-765d60ecf22e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_d629a229-666a-4cc6-a06a-0de2b36c7a44" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a9a4ebb-cf0e-46f8-860b-5888ce87e7e5" xlink:to="loc_dei_SolicitingMaterial_d629a229-666a-4cc6-a06a-0de2b36c7a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_054499af-a8a6-4731-b34d-a0c24c86c4fa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a9a4ebb-cf0e-46f8-860b-5888ce87e7e5" xlink:to="loc_dei_PreCommencementTenderOffer_054499af-a8a6-4731-b34d-a0c24c86c4fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_cffd2731-ddc5-4cb5-b7e2-508260d06602" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a9a4ebb-cf0e-46f8-860b-5888ce87e7e5" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_cffd2731-ddc5-4cb5-b7e2-508260d06602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_af637c4f-13b0-40b0-9c35-876bb4b14aee" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a9a4ebb-cf0e-46f8-860b-5888ce87e7e5" xlink:to="loc_dei_Security12bTitle_af637c4f-13b0-40b0-9c35-876bb4b14aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_9cd5486f-bdd2-4b5b-aa97-33a404d367fb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a9a4ebb-cf0e-46f8-860b-5888ce87e7e5" xlink:to="loc_dei_TradingSymbol_9cd5486f-bdd2-4b5b-aa97-33a404d367fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_29410883-1fbb-4fbf-883b-0c5d9a9a7f44" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a9a4ebb-cf0e-46f8-860b-5888ce87e7e5" xlink:to="loc_dei_SecurityExchangeName_29410883-1fbb-4fbf-883b-0c5d9a9a7f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_68cdade1-7182-4843-8c5f-db982b04f4a8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a9a4ebb-cf0e-46f8-860b-5888ce87e7e5" xlink:to="loc_dei_EntityEmergingGrowthCompany_68cdade1-7182-4843-8c5f-db982b04f4a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_53e105a7-9c8a-4bed-8d09-37bfea4913de" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a9a4ebb-cf0e-46f8-860b-5888ce87e7e5" xlink:to="loc_dei_EntityExTransitionPeriod_53e105a7-9c8a-4bed-8d09-37bfea4913de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_4ba689d9-ad1a-4c35-9a2c-d8cbbe1b6720" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a9a4ebb-cf0e-46f8-860b-5888ce87e7e5" xlink:to="loc_dei_EntityCentralIndexKey_4ba689d9-ad1a-4c35-9a2c-d8cbbe1b6720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_343aeb62-a734-48e4-a0d8-5c70301c63d2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a9a4ebb-cf0e-46f8-860b-5888ce87e7e5" xlink:to="loc_dei_AmendmentFlag_343aeb62-a734-48e4-a0d8-5c70301c63d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>senti_logoxpra.jpg
<TEXT>
begin 644 senti_logoxpra.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  J *8# 2(  A$! Q$!_\0
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M1VR",=,4DGQT\<_#3Q%X<G^(/P>T;P]HFI:A'8+J.FW$<LL,KG"D 9Z<GMD
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MFU8:F/%&K-J8C$'E_9\ECLSN.[[W7CITIB/,OC]#';_M/? &*)%BB2YNU5$
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(@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139984620671392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 15, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 15,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SENTI BIOSCIENCES, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">86-2437900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2 Corporate Drive, First Floor<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">South San Francisco<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">382-3281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SNTI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001854270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>snti-20220815_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="snti-20220815.xsd" xlink:type="simple"/>
    <context id="iedad022569ab46589d8088865d4a1647_D20220815-20220815">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001854270</identifier>
        </entity>
        <period>
            <startDate>2022-08-15</startDate>
            <endDate>2022-08-15</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF80L2ZyYWc6MzBhNTA2ZmYwNTZjNGJjNWFmMDgxYTczYWYxNzQ5Y2QvdGFibGU6YjkzNGFlY2M5MDAxNDFkNTg4OWQzYTNiM2IyOTYzMmEvdGFibGVyYW5nZTpiOTM0YWVjYzkwMDE0MWQ1ODg5ZDNhM2IzYjI5NjMyYV8xLTEtMS0xLTk3MDk5_aaacecfb-f936-4d6a-b3b1-69805fff213a">0001854270</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF80L2ZyYWc6MzBhNTA2ZmYwNTZjNGJjNWFmMDgxYTczYWYxNzQ5Y2QvdGFibGU6YjkzNGFlY2M5MDAxNDFkNTg4OWQzYTNiM2IyOTYzMmEvdGFibGVyYW5nZTpiOTM0YWVjYzkwMDE0MWQ1ODg5ZDNhM2IzYjI5NjMyYV8yLTEtMS0xLTk3MDk5_c18af3b6-ca7d-4f59-b95f-3f05c72f62a7">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGV4dHJlZ2lvbjo5MTRlMWVlMzcxNGE0MjJkODRlYzVmMThmNThiMTc3Ml8xNTAx_1ba8aeb5-948f-4ed5-8739-de403d6ad49e">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGV4dHJlZ2lvbjo5MTRlMWVlMzcxNGE0MjJkODRlYzVmMThmNThiMTc3Ml8yOTU_c12218ed-c90b-4541-af43-9d44cd6b038e">2022-08-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGV4dHJlZ2lvbjo5MTRlMWVlMzcxNGE0MjJkODRlYzVmMThmNThiMTc3Ml8xNTAz_9861ed99-27f4-4428-8878-78687109bf8e">SENTI BIOSCIENCES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGFibGU6ZjA3MmQxNzc2ZmFlNDAzMzk2YmY1MWM3YzhjN2RiYzIvdGFibGVyYW5nZTpmMDcyZDE3NzZmYWU0MDMzOTZiZjUxYzdjOGM3ZGJjMl8wLTAtMS0xLTk3MDk5_76e84846-03ed-4665-9e1f-e9d88074a944">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGFibGU6ZjA3MmQxNzc2ZmFlNDAzMzk2YmY1MWM3YzhjN2RiYzIvdGFibGVyYW5nZTpmMDcyZDE3NzZmYWU0MDMzOTZiZjUxYzdjOGM3ZGJjMl8wLTItMS0xLTk3MDk5_51d9fe62-b599-4204-8dda-1ab43915da0b">001-40440</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGFibGU6ZjA3MmQxNzc2ZmFlNDAzMzk2YmY1MWM3YzhjN2RiYzIvdGFibGVyYW5nZTpmMDcyZDE3NzZmYWU0MDMzOTZiZjUxYzdjOGM3ZGJjMl8wLTQtMS0xLTk3MDk5_aa823154-7d27-4e9b-9816-2b9b384a4b14">86-2437900</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGV4dHJlZ2lvbjo5MTRlMWVlMzcxNGE0MjJkODRlYzVmMThmNThiMTc3Ml8xNTA0_c82ca0a9-db6c-496f-852c-d43593ba2ef5">2 Corporate Drive, First Floor</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGV4dHJlZ2lvbjo5MTRlMWVlMzcxNGE0MjJkODRlYzVmMThmNThiMTc3Ml8xNTA1_e5071077-d917-4bf0-bd6f-83d9d0bc45f1">South San Francisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGV4dHJlZ2lvbjo5MTRlMWVlMzcxNGE0MjJkODRlYzVmMThmNThiMTc3Ml8xNTA2_23284f29-5057-4f0a-980f-bb1505aa752c">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGV4dHJlZ2lvbjo5MTRlMWVlMzcxNGE0MjJkODRlYzVmMThmNThiMTc3Ml81MTg_ccee2189-91a8-47c3-b338-e9115d3db8db">94080</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGV4dHJlZ2lvbjo5MTRlMWVlMzcxNGE0MjJkODRlYzVmMThmNThiMTc3Ml82MzQ_cd70187d-0e06-4ca2-a121-7953d954edef">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGV4dHJlZ2lvbjo5MTRlMWVlMzcxNGE0MjJkODRlYzVmMThmNThiMTc3Ml82Mzg_7ccd335a-a0d0-4787-bc08-6fb16d32a23e">382-3281</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGFibGU6M2M0NjY4NmYzMGYzNDBjYTljMzViNmU4ZjM2YzUyNzMvdGFibGVyYW5nZTozYzQ2Njg2ZjMwZjM0MGNhOWMzNWI2ZThmMzZjNTI3M18wLTAtMS0xLTk3MDk5_a85b7ef8-d496-4317-92d7-696c8f7666d5">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGFibGU6M2M0NjY4NmYzMGYzNDBjYTljMzViNmU4ZjM2YzUyNzMvdGFibGVyYW5nZTozYzQ2Njg2ZjMwZjM0MGNhOWMzNWI2ZThmMzZjNTI3M18yLTAtMS0xLTk3MDk5_65e4a9d4-d379-46ce-90e3-7e30f389ca25">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGFibGU6M2M0NjY4NmYzMGYzNDBjYTljMzViNmU4ZjM2YzUyNzMvdGFibGVyYW5nZTozYzQ2Njg2ZjMwZjM0MGNhOWMzNWI2ZThmMzZjNTI3M180LTAtMS0xLTk3MDk5_4ca5a39e-58bc-474a-91dc-44cd6892dd84">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGFibGU6M2M0NjY4NmYzMGYzNDBjYTljMzViNmU4ZjM2YzUyNzMvdGFibGVyYW5nZTozYzQ2Njg2ZjMwZjM0MGNhOWMzNWI2ZThmMzZjNTI3M182LTAtMS0xLTk3MDk5_c997b641-e9af-4136-8f84-becb30a8a263">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGFibGU6YjgzZjdiNTE4NThjNGE4MTk5MTEyYTNjNTVlYzIyOTAvdGFibGVyYW5nZTpiODNmN2I1MTg1OGM0YTgxOTkxMTJhM2M1NWVjMjI5MF8xLTAtMS0xLTk3MDk5_c33fb9e2-019f-441e-b163-8b53941f9832">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGFibGU6YjgzZjdiNTE4NThjNGE4MTk5MTEyYTNjNTVlYzIyOTAvdGFibGVyYW5nZTpiODNmN2I1MTg1OGM0YTgxOTkxMTJhM2M1NWVjMjI5MF8xLTItMS0xLTk3MDk5_88fa3dab-d47c-46ed-b6ec-bf0253d54251">SNTI</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGFibGU6YjgzZjdiNTE4NThjNGE4MTk5MTEyYTNjNTVlYzIyOTAvdGFibGVyYW5nZTpiODNmN2I1MTg1OGM0YTgxOTkxMTJhM2M1NWVjMjI5MF8xLTQtMS0xLTk3MDk5_50f2e64a-c436-4f85-a794-5b57a4ad8631">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGV4dHJlZ2lvbjo5MTRlMWVlMzcxNGE0MjJkODRlYzVmMThmNThiMTc3Ml8xNDk5_392eb7ba-ce20-4006-b582-c3f989e3b56e">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="iedad022569ab46589d8088865d4a1647_D20220815-20220815"
      id="id3VybDovL2RvY3MudjEvZG9jOmUxM2E2NjliODU4NDQyMGU5MDExMjhlOWE2MTgyMmE0L3NlYzplMTNhNjY5Yjg1ODQ0MjBlOTAxMTI4ZTlhNjE4MjJhNF8xL2ZyYWc6OTE0ZTFlZTM3MTRhNDIyZDg0ZWM1ZjE4ZjU4YjE3NzIvdGV4dHJlZ2lvbjo5MTRlMWVlMzcxNGE0MjJkODRlYzVmMThmNThiMTc3Ml8xNTAw_fd3e9e16-c269-420c-ae5b-e5ace49b323d">true</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M 0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4
M-5"I0P5,75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K
M!LIDR^SO *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1U
MW6E\./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@
M;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ U8 /5660>9(9
M 0  SP,  !,   !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL
M6*"F&V +77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4
M'5%\% )5!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I
M>.EY&TWP39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY
M'7#J>SM 2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?K
MT70Q32:>,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;
M@[Z1S>/]#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"
M% ,4    " #5@ ]5!T%-8H$   "Q    $               @ $     9&]C
M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( -6 #U4YR+R@[P   "L"   1
M          "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( -6
M#U697)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ U8 /51%]F EN!   +!$  !@
M ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( -6
M#U6?H!OPL0(  .(,   -              "  ;(,  !X;"]S='EL97,N>&UL
M4$L! A0#%     @ U8 /59>*NQS     $P(   L              ( !C@\
M %]R96QS+RYR96QS4$L! A0#%     @ U8 /5:K$(A8S 0  (@(   \
M         ( !=Q   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( -6 #U4D
M'INBK0   /@!   :              "  =<1  !X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<U!+ 0(4 Q0    ( -6 #U5ED'F2&0$  ,\#   3
M      "  ;P2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(
'  84      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="snti-20220815.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sentibio.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="snti-20220815.htm">snti-20220815.htm</File>
    <File>a202208158kex991.htm</File>
    <File>snti-20220815.xsd</File>
    <File>snti-20220815_lab.xml</File>
    <File>snti-20220815_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "snti-20220815.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "snti-20220815.htm"
     ]
    },
    "labelLink": {
     "local": [
      "snti-20220815_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "snti-20220815_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "snti-20220815.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "snti",
   "nsuri": "http://www.sentibio.com/20220815",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "snti-20220815.htm",
      "contextRef": "iedad022569ab46589d8088865d4a1647_D20220815-20220815",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.sentibio.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "snti-20220815.htm",
      "contextRef": "iedad022569ab46589d8088865d4a1647_D20220815-20220815",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sentibio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sentibio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sentibio.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sentibio.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sentibio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sentibio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sentibio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sentibio.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sentibio.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sentibio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sentibio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sentibio.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sentibio.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sentibio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sentibio.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sentibio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sentibio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sentibio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sentibio.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sentibio.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sentibio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sentibio.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sentibio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001854270-22-000018-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001854270-22-000018-xbrl.zip
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MY1>K/&&M?4PNI@ R'F2=GX#Z^R.SW=MFB_/7U2[ ='W*RUO*70.PHXN,J*N
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MJB-8IY:V]L(I/KR1M"]>"Q)/3F]!%]39)UP4O\?3^F)"?NE(Y/4^Y4Z[--*
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M4+$6MV)L?'5LPI_:(*ECBUO1AP\%%H/A:Q5-%C&U(J0?^(Y%DID^H @?LW=
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M'NA(?I^&KGGH=?97Q<85#'FBW6DUO/W&JGJDPB'WHNV5PG8D?T)A?)^FK=5
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MVF&1,"\$\(>\'R<9VIA^YQ0,#)YFB%\*SVF2%W/VH?H<'/EK;N;4"^/GMNN
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M-9 HV&52@#U/AE\H-8!]E+9W@<QA\7HAO;N;S[:97V/8K>@T[!<.Z[>T4S+
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MCMQ!_D"DI*)M=3[O$-9)6B?LB]<M5SC<KOWWBPWT@OU:+T>_ 5!+ P04
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MUEGOZUO;R_][F565S.N5O9M\_2S,<@9A#&5 (Q#7>L<L"@&1E $1^$1(243
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M6H%YS]RXZ,^X)_ER\;86]3>K1^(=XX']G=LO^I?^?TGL[_P?4$L! A0#%
M  @ U8 /5;M:-(:L(   $Q<! !0              ( !     &$R,#(R,#@Q
M-3AK97@Y.3$N:'1M4$L! A0#%     @ U8 /5?AFS2_M%   &)@  !$
M         ( !WB   '-N=&DM,C R,C X,34N:'1M4$L! A0#%     @ U8 /
M54%</>)I @  ;@<  !$              ( !^C4  '-N=&DM,C R,C X,34N
M>'-D4$L! A0#%     @ U8 /5<!I:XRL"@  _V   !4              ( !
MDC@  '-N=&DM,C R,C X,35?;&%B+GAM;%!+ 0(4 Q0    ( -6 #U5O#8WU
MVP8  /,R   5              "  7%#  !S;G1I+3(P,C(P.#$U7W!R92YX
8;6Q02P4&      4 !0!& 0  ?TH

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
